pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
INNA-051
Viral Respiratory Tract Infection
ENA Respiratory Pty Ltd
0 catalysts
Phase 2
INV-9956
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ionova Life Science Co Ltd
0 catalysts
Phase 2
INX-315
Epithelial Ovarian Cancer
Incyclix Bio LLC
0 catalysts
Phase 2
ION-283
Lafora Disease (Unverricht Disease)
← prev
page 15 of 50
next →
131
Pain89
Neurology1
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
ION-356
Pelizaeus-Merzbacher Disease (PMD)
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
IOV-2001
Chronic Lymphocytic Leukemia (CLL)
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 2
IOV-4001
Metastatic Melanoma
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 2
IPG-7236
Head And Neck Cancer
Immunophage Biotech Co Ltd
0 catalysts
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
0 catalysts
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
0 catalysts
Phase 2
IRX-4204
Parkinson's Disease
Retinoid X receptor
Io Therapeutics Inc
0 catalysts
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
0 catalysts
Phase 2
ISP-001
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Immusoft Corp
0 catalysts
Phase 2
IVB-001
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Invictus Therapeutics Ltd
0 catalysts
Phase 2
IVMED-80
Keratoconus
$GKOSGLAUKOS Corp
0 catalysts
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
0 catalysts
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
0 catalysts
Phase 2
ImMucin
Multiple Myeloma (Kahler Disease)
Vaxil Bio Therapeutics Ltd
0 catalysts
Phase 2
JAB-23E73
Metastatic Colorectal Cancer
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
JAB-2485
Small-Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 2
JAB-30355
Solid Tumor
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 2
JAG-201
Autism Spectrum Disorder (ASD)
Jaguar Gene Therapy LLC
0 catalysts
Phase 2
JBI-778
Adenoid Cystic Carcinoma (ACC)
Jubilant Therapeutics Inc
0 catalysts
Phase 2
JBI-802
Neuroendocrine Tumors
Jubilant Therapeutics Inc
0 catalysts
Phase 2
JCXH-105
Herpes Zoster (Shingles)
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Phase 2
JCXH-107
Seasonal Influenza
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Phase 2
JCXH-221
Coronavirus Disease 2019 (COVID-19)
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Phase 2
JIN-A02
Non-Small Cell Lung Cancer
J Ints Bio Co Ltd
0 catalysts
Phase 2
JK-07
Diastolic Heart Failure (HFpEF)
Salubris Biotherapeutics Inc
0 catalysts
Phase 2
JNJ-2056
Alzheimer's Disease
Johnson & Johnson Innovative Medicine
0 catalysts